Source: Annual Congress 2005 - PG11 - Experimental models for COPD and asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Braun (Hannover, Germany). Models to mimic allergic asthma using house dust mite or Aspergillus fumigatus in mice: advantages and disadvantages. Annual Congress 2005 - PG11 - Experimental models for COPD and asthma

Member's Comments

No comment yet.

Related content which might interest you: Allergyprotective effects of Staphylococcus scuiri in a house dust mite (HDM) model of allergic airway inflammation Source: Annual Congress 2012 - Asthma: risk factors and effect of anti-IgE Year: 2012 House dust mite induces direct airway inflammation in vivo: implications for future disease therapy? Source: Eur Respir J 2010; 35: 1377-1387 Year: 2010 Calcaratarin D attenuates house dust mite-induced allergic asthma Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021 Bacteria and mould components in house dust and children's allergic sensitisation Source: Eur Respir J 2007; 29: 1144-1153 Year: 2007 The effect of BCG treatment on the remodelling in the house dust mite induced allergic asthma in mice Source: Eur Respir J 2005; 26: Suppl. 49, 580s Year: 2005 OPURIT: Omalizumab-protected ultra rush specific immunotherapy in severe asthmatic patients with house dust mite allergy Source: Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E Year: 2011 Local lung house dust mite (HDM) challenges induce cell necrosis in mouse experimental asthma Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD Year: 2020 The effect of montelukast during allergen sensitization period in house dust mite mouse model Source: International Congress 2017 – "Alarming" immunological patterns in asthma Year: 2017 Monitoring spirometry-like parameters in mice with house dust mite-induced experimental asthma Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease Year: 2021 YS2: Role of Th9 cells in allergic airway inflammation induced by house dust mite Source: Lung Science Conference 2011 - Immune system dysregulation in chronic lung disease Year: 2011 Polymorphisms of IL-4/IL4R alpha genes in house dust mite allergic asthma patients Source: Eur Respir J 2005; 26: Suppl. 49, 141s Year: 2005 Efficacy of specific allergy vaccination in house dust mite asthma Source: Eur Respir J 2005; 26: Suppl. 49, 465s Year: 2005 House dust mite sublingual immunotherapy reduces type 2 biomarkers in allergic asthma Source: Virtual Congress 2020 – Management of allergy, asthma and COPD Year: 2020 Levels of house dust mites (HDM) in homes of patients with bronchial asthma (BA) and the airway inflammation Source: Eur Respir J 2001; 18: Suppl. 33, 281s Year: 2001 Respiratory symptoms in relation to indoor exposure to mite and cat allergens and endotoxins Source: Eur Respir J 2001; 18: 555-563 Year: 2001 Sensitisation to house dust mite: its association with bronchial hyperresponsiveness and lung function in asthmatic children Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009 Implication of NOD-1 receptor in an experimental house dust mite-induced asthma model Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases Year: 2018 A house dust mite-induced asthma model in transcutaneously sensitized mice Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010 Sublingual immunotherapy is an established therapy for house dust mite sensitive allergic rhinitis and/or asthma Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities Year: 2007 Association between Th2 biomarker levels and efficacy of house dust mite sublingual allergy immunotherapy in adults with allergic asthma Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies Year: 2021